article thumbnail

ServiceNow Eyes San Diego Investments As Part Of $100M Fund

socalTECH

ServiceNow, the digital workflow and service management software developer which has operations in San Diego, said today that it has launched a new $100M investment fund, part of which will look at investments in San Diego.

San Diego 113
article thumbnail

Design Therapeutics Finds $45M

socalTECH

San Diego-based Design Therapeutics , which is developing therapies for patients with serious degenerative disorders caused by nucleotide repeat expansions, has raised $45M in a Series A financing round. The round was led by SR One, and also included Cormorant Asset Management, Quan Capital and WestRiver Group.

Design 113
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Entos Finds $53M For Drug Design Platform

socalTECH

San Diego-based Entos, a developer of artificial intelligence and automated synthetic development technology for designing small-molecule therapeutics, has raised $53M in a Series A funding. The funding was led by Coatue, and also included Catalio Capital Management, OrbiMed, Sequoia CApital, Nexus Ventures, and Freeflow.

Design 113
article thumbnail

Design Therapeutics Picks Up $125M For Small Molecules

socalTECH

San Diego-based Design Therapeutics, a biotech company which is developing small molecules for the treatment of serious degenerative disorders caused by inherited nucleotide repeat expansions, said it has raised $125M in its Series B funding round. Wellington Management, Avoro Capital Advisors, Vivo Capital, and others.

Design 113
article thumbnail

Xconomy Guide to Best Sessions at Startup Week San Diego

Xconomy

Startup Week San Diego, like a lot of other places that host similar events, has been billed as a weeklong celebration of entrepreneurship. But while Startup Week San Diego has always collaborated with UP Global, San Diego entrepreneur and Startup Week organizer Austin Neudecker said, “We’ve always been an independent entity.”.

article thumbnail

ViaCyte Scores $45M For Stem Cell Therapy

socalTECH

San Diego-based ViaCyte, a company which is using stem cell technology to develop treatments for Type 1 Diabetes, says it has raised $45M in an extension of its Series D funding round. The funding brings its Series D funding to more than $115M. ViaCyte is led by President and CEO Michael Yang.

San Diego 113
article thumbnail

Veni, Vidi, Vinti: What Internet Pioneer Vint Cerf Sees in San Diego

Xconomy

The Internet pioneer Vinton Cerf came to San Diego recently on an unusual quest—to meet with dozens of local technology leaders and assess what the region has to offer in terms of innovation. The visit was unusual in part because of Cerf himself.